Medical technology products manufacturer Trivitron Group of Companies, has formed an alliance with BioSystems, Spain, to manufacture in-vitro diagnostic (IVD) reagents.

It should be noted that this is the third manufacturing joint venture for Trivitron in recent times. Earlier, the firm has signed joint ventures with Brandon Medical for making operation theatre bulbs and Aloka of Japan for portable ultrasound scanners.

Property developer Indiabulls Real Estate (IBREL) has informed that company's board of directors has finally approved a plan to raise $600 million (Rs 3,000 crore) through qualified institutional placement (QIP) of securities.

The QIP proceeds are expected to be utilized for funding its power projects, mainly a 1,320-megawatt project planned in Amaravati in Maharashtra.

The board of directors took a decision to this effect at its meeting on April 24 (Friday).

Covidien, a $10 billion global healthcare products leader, has announced its entry into the Indian healthcare market with the establishment of its headquarters at Gurgaon.

The company intends to collaborate with the region's healthcare providers to offer its cutting-edge medical solutions and services throughout the country.

According to sources, Covidien will setup three 'dry labs' this year to initiate training programmes for medical practitioners in the country. In addition, it will also introduce some of its patented products in India.

Shantha Biotechnics, a pioneer in the biotechnology field, has made announcement about the launching of its bivalent oral cholera vaccine, 'Shanchol'.

Shanchol, which is believed to the first of its kind in the world, will be launched on Sunday during a two-day seminar on Continuous Medical Education (CME) of National Infectious Diseases organized by Indian Academy of Pediatrics at Kolkata.

Rajasthan-based Shree Cement Ltd has decided to invest Rs 1,200 crore in the current financial year to expand its production capacity, including setting up two greenfield plants and installing four captive power plants.

According to company officials, the investments would be made in two grinding units in Rajasthan and Uttaranchal, and two power plants of 50MW each at Bangur city.

The Godrej group has exited the pest control service business by selling its entire shareholding in Godrej HiCare to ISS a leading Denmark-based facility services company at a consideration of around Rs 100 crore.

Godrej group flagship, Godrej Industries, had a controlling stake of about 80% in Godrej HiCare, while the balance 20% being held by individuals like A Mahendran, director, Godrej HiCare.